These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36597354)

  • 1. Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
    Belaunzarán-Zamudio PF; Naranjo L; Caro-Vega Y; Castillo-Mancilla JR; Camiro-Zuñiga A; Fuentes-García R; Crabtree-Ramírez BE; Sierra-Madero JG
    AIDS Res Hum Retroviruses; 2023 Mar; 39(3):136-144. PubMed ID: 36597354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
    Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d'Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC;
    Clin Infect Dis; 2024 Apr; 78(4):995-1004. PubMed ID: 38092042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of age at antiretroviral therapy initiation with CD4 +  : CD8 + ratio recovery among virally suppressed people with HIV.
    Holden CJ; Lampe FC; Burns FM; Chaloner C; Johnson M; Kinloch-De Loes S; Smith CJ
    AIDS; 2024 Apr; 38(5):703-711. PubMed ID: 38016172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
    Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
    Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression.
    Castillo-Mancilla JR; Morrow M; Boum Y; Byakwaga H; Haberer JE; Martin JN; Bangsberg D; Mawhinney S; Musinguzi N; Huang Y; Tracy RP; Burdo TH; Williams K; Muzzora C; Hunt PW; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):507-513. PubMed ID: 29346185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
    Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
    Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
    Castillo-Mancilla JR; Phillips AN; Neaton JD; Neuhaus J; Sharma S; Baker JV; Collins S; Mannheimer S; Pett S; Touzeau-Römer V; Polizzotto MN; Lundgren JD; Gardner EM;
    J Int AIDS Soc; 2019 Jun; 22(6):e25297. PubMed ID: 31250552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, trends in CD4+/CD8+ cell ratio, and clinical outcomes with persistent HIV suppression in a dynamic cohort of ambulatory HIV patients.
    Novak RM; Armon C; Battalora L; Buchacz K; Li J; Ward D; Carlson K; Palella FJ;
    AIDS; 2022 May; 36(6):815-827. PubMed ID: 35013081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
    Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
    J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
    T Tchakoute C; Rhee SY; Hare CB; Shafer RW; Sainani K
    PLoS One; 2022; 17(2):e0263742. PubMed ID: 35157724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy.
    Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.